Ascorbate in Myelodysplastic Syndrome
NCT07283900
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
38
Enrollment
OTHER
Sponsor class
Conditions
Myelodysplastic Syndromes
Interventions
DRUG:
High-dose ascorbate
DRUG:
Azacitidine
Sponsor
Prajwal Dhakal